In this double-blind , multi-centre Phase III study , patients aged 20 years with hemoglobin A1c ( HbA1c ) 7.0-10 .0 % on diet/exercise therapy alone received placebo or canagliflozin ( 100 or 200 mg ) once daily for 24 weeks .